Early Phase 1 Primary Biliary Cholangitis Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You must have signed and dated a consent form agreeing to take part in the study
• You must have already completed a previous clinical trial for a liver condition called PBC (primary biliary cholangitis) that used a medication called fenofibrate (trial reference NCT06591455)
• If you are a woman who could become pregnant, you must be willing to use at least one barrier method of contraception (such as a condom or diaphragm) plus a second form of birth control during the study and for at least 90 days after your last dose
• If you are a man who is sexually active with a woman who could become pregnant, you must use a barrier method of contraception, and your female partner must also use a second form of birth control during the study and for at least 90 days after your last dose

Who may not be able to join:

• If you had to stop taking the study drug in a previous PBC trial due to a side effect or bad reaction to the treatment, you may not be eligible
• If you have another health condition (other than PBC) that the study doctor believes would prevent you from fully participating or might affect the study results, you may not be eligible (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.